Systemic Sclerosis Associated Interstitial Lung Disease and Nintedanib: A Rare Disease and a Promising Drug

Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is a rare disease with a progressive nature, eventually leading to lung fibrosis. Nintedanib, a tyrosine kinase inhibitor, is a widely accepted drug for treating idiopathic pulmonary fibrosis (IPF), a disease that shares some similari...

Descripción completa

Detalles Bibliográficos
Autores principales: Kafle, Sunam, Thapa Magar, Manusha, Patel, Priyanka, Poudel, Arisa, Cancarevic, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364831/
https://www.ncbi.nlm.nih.gov/pubmed/34414042
http://dx.doi.org/10.7759/cureus.16404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364831/
https://www.ncbi.nlm.nih.gov/pubmed/34414042
http://dx.doi.org/10.7759/cureus.16404

Ejemplares similares